Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
BW Businessworld

Mankind Pharma Buys Majority Stake In D2C Brand Upakarma Ayurveda

Upakarma Ayurveda is engaged in developing, manufacturing and selling of ayurvedic and herbal products

Photo Credit : constructive.net.au

1489076168_QEFjUE_deals.jpg

Pharmaceutical giant Mankind Pharma has acquired a majority stake in D2C startup brand Upakarma Ayurveda through one of its subsidiaries. However, the terms of the deal are unknown. 

The New Delhi-based Upakarma Ayurveda is engaged in developing, manufacturing and selling of ayurvedic and herbal products. The company's decision to invest will empower Upakarma Ayurveda to develop a wider range of products and offerings, Mankind Pharma said in a statement on Monday.

Mankind Pharma Vice Chairman and Managing Director Rajeev Juneja said that the current lifestyle has become strenuous where people find it difficult to focus on their health. “To fulfil their requirements, consumers are considering Ayurvedic remedies for long-term sustenance and boosting immunity over time. As Mankind Pharma works towards improving the healthcare of people, we have associated with Upakarma Ayurveda in order to cater to the emerging needs of consumers," 

Upakarma Ayurveda Founder & Managing Director Vishal Kaushik said that with the partnership, the company is hopeful that quality ayurvedic solutions will reach far and wide.

Founded by brothers Vishal Kaushik and Parag Kaushik in 2017, Upakarma Ayurveda has so far raised around USD 1 million from multiple investors.